Androgen Receptor (AR) Test | Lahalak Medical Platform
Assessment of androgen receptor levels in cancer cells to guide hormonal therapy in prostate and breast cancers, helping select the most appropriate treatment for the patient.
Scientific name: Immunohistochemistry: Androgen Receptor (AR)
A qualitative and quantitative immunohistochemical (IHC) assay using a monoclonal antibody against the androgen receptor (AR) aims to detect the presence and level of nuclear expression of the AR protein in tumor tissues. AR is a hormone-dependent transcription factor involved in the growth and proliferation of androgen-sensitive cells.
Service type
Immunohistochemical Tissue Test
Duration
20-30 minutes
Fasting
Fasting is not required
Included Services
- Detailed analysis to diagnose androgen receptor (AR) expression in tumor tissue
- Consult a specialist to interpret the results.
- Personal support services from Lahalak
Medical Service Information
Conditions & Notices
- Essential requirement: A recent or well-preserved FFPE tissue mass from the primary tumor or metastasis is available. AR antigens can degrade in very old samples.
- The examination must be preceded by a confirmed histological diagnosis (H&E) of the type of tumor (prostate, breast, etc.).
- In breast cancer, the estrogen receptor (ER) and progesterone receptor (PR) assay must be negative to establish triple negative status before considering the significance of AR.
- Delivery time: 5-7 business days.
Medical services you might also like
